Hyundai BioLand Co Ltd
KOSDAQ:052260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hyundai BioLand Co Ltd
KOSDAQ:052260
|
KR |
|
Shriram Finance Ltd
NSE:SHRIRAMFIN
|
IN |
|
Grupo Gigante SAB de CV
BMV:GIGANTE
|
MX |
|
China Feihe Ltd
HKEX:6186
|
CN |
|
C
|
Covetrus Inc
F:2NJ
|
US |
|
General Elevator Co Ltd
SZSE:300931
|
CN |
|
Tata Steel Ltd
NSE:TATASTEEL
|
IN |
|
L
|
Litu Holdings Ltd
HKEX:1008
|
CN |
|
Trelleborg AB
STO:TREL B
|
SE |
|
J
|
Joong Ang Enervis Co Ltd
KOSDAQ:000440
|
KR |
|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
US |
|
Jiangsu Lihua Animal Husbandry Co Ltd
SZSE:300761
|
CN |
|
S
|
Shanghai Smart Control Co Ltd
SZSE:001266
|
CN |
|
Wenling Zhejiang Measuring and Cutting Tools Trading Centre Co Ltd
HKEX:1379
|
CN |
|
Tatwah Smartech Co Ltd
SZSE:002512
|
CN |
|
InCity Immobilien AG
XETRA:IC8
|
DE |
|
P
|
Palfinger AG
VSE:PAL
|
AT |
|
C
|
Centennial Resource Development Inc
F:241A
|
US |
|
Verite Co Ltd
TSE:9904
|
JP |
|
Jinhong Fashion Group Co Ltd
SSE:603518
|
CN |
Hyundai BioLand Co Ltd
HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2001-05-17. The firm operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2001-05-17. The firm operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
